Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest ...

From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update ...

Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene ...

Lonza, the Swiss Biotech firm that purchased Vacaville’s Genentech plant from Roche in 2024, released a streamlined operating model and invitations to its Annual General Meeting in Basel, ...

Chinese drug makers landed 33 licensing deals with overseas pharmaceutical firms, with transactions totalling US$36.2 billion ...

As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on ...

Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...

Food and agriculture remain significantly underfunded compared to other climate tech investments. The World Bank estimates that only 2.5%–4% of global climate ...

LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics ...

President Donald Trump surprised global markets with his much-anticipated announcement of sweeping import tariffs. How will ...

Marcel Botha, CEO of 10XBeta, explore the role collaboration between private industry, government agencies, and research institutions plays in strengthening pandemic preparedness and ensuring medical ...